Home » Stocks » BAX

Baxter International, Inc. (BAX)

Stock Price: $77.38 USD -4.53 (-5.53%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 41.19B
Revenue (ttm) 11.82B
Net Income (ttm) 1.07B
Shares Out 505.00M
EPS (ttm) 2.07
PE Ratio 37.38
Forward PE 23.64
Dividend $0.98
Dividend Yield 1.27%
Trading Day July 29
Last Price $77.38
Previous Close $81.91
Change ($) -4.53
Change (%) -5.53%
Day's Open 78.50
Day's Range 77.31 - 80.49
Day's Volume 7,327,511
52-Week Range 74.06 - 88.02

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 day ago - Zacks Investment Research

According to people familiar with the matter, Baxter International Inc (NYSE: BAX) is reportedly in talks to buy Hill-Rom Holdings Inc (NYSE: HRC). The talks are at an early stage, some of the people sa...

1 day ago - Benzinga

Baxter's (BAX) second-quarter results are likely to reflect growth in its Acute Therapies business.

6 days ago - Zacks Investment Research

Baxter (BAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 week ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, recognizes the findings of a large retrospective observational analysis publishe...

2 weeks ago - Business Wire

The Company's new quarterly dividend payment of $0.3125 per share of Conagra common stock will be paid on September 2, 2021 to stockholders of record as of the close of business on August 3, 2021.

Other stocks mentioned: AON, CAG, DUK, FAST
2 weeks ago - Forbes

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...

2 weeks ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2020 Corporate Responsibility Report. This year's report details fin...

3 weeks ago - Business Wire

Here are three stocks, BAX, BRBR, and MRVI with a favorable Zacks Rank and huge prospects in child healthcare at present.

Other stocks mentioned: ABT, BRBR, MRVI
3 weeks ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter Announces $1.2 Million in Funding to Support Students Pursuing Health and Sciences Degrees at HBCUs w/Activating Change Today (ACT) Initiative

1 month ago - Business Wire

NEWTON, Mass.--(BUSINESS WIRE)--Hospital IQ, the leading provider of predictive hospital operations and communications software, secured $25 million in Series C funding led by Baxter Ventures, the ventu...

1 month ago - Business Wire

Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.

Other stocks mentioned: BDX, HSIC, VEEV
1 month ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second-quarter 2021 financial results on Thu...

1 month ago - Business Wire

Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.

1 month ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)-- #HDx--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing expanded hemodialysis (HDx) therapy enabled by the Thera...

1 month ago - Business Wire

Baxter (BAX) introduces new clinical management resource within the Sharesource remote patient management platform for home dialysis patients.

1 month ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)-- #DigitalHealth--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the Sharesource Analytics 1.0 premium module, the...

1 month ago - Business Wire

Baxter's (BAX) PrisMax 2 aims to enhance user experience and help in addressing the unique demands of the ICU.

1 month ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company's next-generation...

2 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. ...

2 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company's quarterly cash dividend to a rate of $0.28...

2 months ago - Business Wire

Baxter's (BAX) first-quarter results reflect robust performance across five of its business units.

3 months ago - Zacks Investment Research

Baxter (BAX) delivered earnings and revenue surprises of 18.75% and 1.73%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2021. “Baxter's medically essential pro...

3 months ago - Business Wire

Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

3 months ago - Zacks Investment Research

Baxter's (BAX) first-quarter results are likely to reflect growth in its Acute Therapies business.

3 months ago - Zacks Investment Research

Baxter (BAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countri...

3 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Mini...

3 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May...

3 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that, due to the public health and safety concerns related to the novel...

3 months ago - Business Wire

DEERFIELD, Ill. & WASHINGTON--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, and the Central Area of The Links, Incorporated, an international not-for-...

4 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2021 financial results on Thur...

4 months ago - Business Wire

Baxter (BAX) gets FDA approval for its AK 98 Hemodialysis machine that offers a compact, portable and easy-to-use system for dialysis providers.

4 months ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation Artific...

4 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 1...

4 months ago - Business Wire

Baxter International Inc (NYSE: BAX) has agreed to provide manufacturing services for Moderna Inc's (NASDAQ: MRNA) COVID-19 Vaccine. The agreement includes fill/finish sterile manufacturing services and...

Other stocks mentioned: MRNA
4 months ago - Benzinga

DEERFIELD, Ill., AND CAMBRIDGE, Mass..--(BUSINESS WIRE)--Baxter BioPharma Solutions and Moderna announce agreement for fill/finish manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Other stocks mentioned: MRNA
4 months ago - Business Wire

Baxter (BAX) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

Generation Investment Management, the firm co-founded by Al Gore (Trades, Portfolio) and David Blood, disclosed this month that its top four buys during the fourth quarter of 2020 included a new positio...

Other stocks mentioned: BABA, EFX, ILMN
5 months ago - GuruFocus

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia Sc...

5 months ago - Business Wire

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $...

5 months ago - Business Wire

Baxter's (BAX) fourth-quarter results reflect robust performance across five of its business units.

5 months ago - Zacks Investment Research

Baxter (BAX) delivered earnings and revenue surprises of 5.26% and 0.83%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Baxter International (NYSE:BAX) moved higher by 0.3% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 1700.00% over the past year to $0.80...

5 months ago - Benzinga

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended December 31, 2020, an...

5 months ago - Business Wire

Baxter's (BAX) fourth-quarter performance is likely to reflect growth in its Acute Therapies business.

5 months ago - Zacks Investment Research

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, ...

6 months ago - Business Wire

The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.

Other stocks mentioned: BSX, MDT, SYK, TMO, XLV
6 months ago - The Motley Fool

About BAX

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1931
CEO
Jose Almeida
Employees
50,000
Stock Exchange
NYSE
Ticker Symbol
BAX
Full Company Profile

Financial Performance

In 2020, BAX's revenue was $11.67 billion, an increase of 2.74% compared to the previous year's $11.36 billion. Earnings were $1.10 billion, an increase of 10.09%.

Financial Statements

Analyst Forecasts

According to 19 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is 93.79, which is an increase of 21.21% from the latest price.

Price Target
$93.79
(21.21% upside)
Analyst Consensus: Buy